The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for anemia in CKD provides an ungraded guideline to sample hemoglobin (Hb) monthly and ferritin and transferrin saturation (TSAT) every 3 months in patients undergoing hemodialysis (HD)3. This evidence concerns the gene GSTM1 and anemia.